Search Results

There are 52604 results for: content related to: The Pleiotropic Effects of Angiotensin Receptor Blockers

  1. Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension

    Intervention Review

    The Cochrane Library

    Balraj S Heran, Michelle MY Wong, Inderjit K Heran and James M Wright

    Published Online : 8 OCT 2008, DOI: 10.1002/14651858.CD003822.pub2

  2. Angiotensin receptor blockers for heart failure

    Intervention Review

    The Cochrane Library

    Balraj S Heran, Vijaya M Musini, Ken Bassett, Rod S Taylor and James M Wright

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD003040.pub2

  3. You have free access to this content
    Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer

    The EMBO Journal

    Volume 30, Issue 19, October 5, 2011, Pages: 3962–3976, Biswajyoti Sahu, Marko Laakso, Kristian Ovaska, Tuomas Mirtti, Johan Lundin, Antti Rannikko, Anna Sankila, Juha-Pekka Turunen, Mikael Lundin, Juho Konsti, Tiina Vesterinen, Stig Nordling, Olli Kallioniemi, Sampsa Hautaniemi and Olli A Jänne

    Version of Record online : 13 SEP 2011, DOI: 10.1038/emboj.2011.328

  4. You have free access to this content
    Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults

    Intervention Review

    The Cochrane Library

    Zui Zou, Hong B Yuan, Bo Yang, Fengying Xu, Xiao Y Chen, Guan J Liu and Xue Y Shi

    Published Online : 27 JAN 2016, DOI: 10.1002/14651858.CD009210.pub2

  5. Latent Trajectory Classes for Alcohol-Related Blackouts from Age 15 to 19 in ALSPAC

    Alcoholism: Clinical and Experimental Research

    Volume 39, Issue 1, January 2015, Pages: 108–116, Marc A. Schuckit, Tom L. Smith, Jon Heron, Matthew Hickman, John Macleod, Marcus R. Munafo, Kenneth S. Kendler, Danielle M. Dick and George Davey-Smith

    Version of Record online : 16 DEC 2014, DOI: 10.1111/acer.12601

  6. Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence

    Birth Defects Research Part A: Clinical and Molecular Teratology

    Volume 94, Issue 8, August 2012, Pages: 576–598, Janine E. Polifka

    Version of Record online : 17 JUL 2012, DOI: 10.1002/bdra.23027

  7. You have free access to this content
    Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment

    International Journal of Urology

    Volume 15, Issue 1, January 2008, Pages: 19–26, Hiroji Uemura, Hitoshi Ishiguro and Yoshinobu Kubota

    Version of Record online : 19 NOV 2007, DOI: 10.1111/j.1442-2042.2007.01937.x

  8. You have free access to this content
    The importance of managing cardiovascular risk in the treatment of hypertension: The role of ACE inhibitors and ARBs

    Journal of the American Academy of Nurse Practitioners

    Volume 20, Issue 11, November 2008, Pages: 529–538, Charon A. Pierson, Benjamin J. Epstein and Mary Ellen Roberts

    Version of Record online : 31 OCT 2008, DOI: 10.1111/j.1745-7599.2008.00364.x

  9. You have free access to this content
    Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients

    Intervention Review

    The Cochrane Library

    Ling Zhang, Xiaoxi Zeng, Ping Fu and Hong Mei Wu

    Published Online : 23 JUN 2014, DOI: 10.1002/14651858.CD009120.pub2

  10. Therapeutic targeting of angiotensin II receptor type 1 to regulate androgen receptor in prostate cancer

    The Prostate

    Volume 72, Issue 14, 1 October 2012, Pages: 1559–1572, Satoru Takahashi, Hiroji Uemura, Azman Seeni, Mingxi Tang, Masami Komiya, Ne Long, Hitoshi Ishiguro, Yoshinobu Kubota and Tomoyuki Shirai

    Version of Record online : 16 MAR 2012, DOI: 10.1002/pros.22505

  11. You have free access to this content
    Presidential Address: Sophisticated Investors and Market Efficiency

    The Journal of Finance

    Volume 64, Issue 4, August 2009, Pages: 1517–1548, JEREMY C. STEIN

    Version of Record online : 16 JUL 2009, DOI: 10.1111/j.1540-6261.2009.01472.x

  12. You have free access to this content
    Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study

    European Journal of Heart Failure

    Volume 14, Issue 10, October 2012, Pages: 1179–1188, Kanan Patel, Gregg C. Fonarow, Dalane W. Kitzman, Inmaculada B. Aban, Thomas E. Love, Richard M. Allman, Mihai Gheorghiade and Ali Ahmed

    Version of Record online : 18 FEB 2014, DOI: 10.1093/eurjhf/hfs101

  13. You have free access to this content
    Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure — A population study

    European Journal of Heart Failure

    Volume 9, Issue 6-7, June-July 2007, Pages: 602–609, Marie Hudson, Elham Rahme, Hassan Behlouli, Richard Sheppard and Louise Pilote

    Version of Record online : 11 MAY 2007, DOI: 10.1016/j.ejheart.2007.02.001

  14. You have free access to this content
    Tissue-specific pioneer factors associate with androgen receptor cistromes and transcription programs

    The EMBO Journal

    Volume 33, Issue 4, 18 February 2014, Pages: 312–326, Päivi Pihlajamaa, Biswajyoti Sahu, Lauri Lyly, Viljami Aittomäki, Sampsa Hautaniemi and Olli A Jänne

    Version of Record online : 22 JAN 2014, DOI: 10.1002/embj.201385895

  15. You have free access to this content
    Angiotensin Receptor Blockers: Pharmacology, Efficacy, and Safety

    The Journal of Clinical Hypertension

    Volume 13, Issue 9, September 2011, Pages: 677–686, Addison A. Taylor, Helmy Siragy and Shawna Nesbitt

    Version of Record online : 27 JUL 2011, DOI: 10.1111/j.1751-7176.2011.00518.x

  16. The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus

    Diabetes, Obesity and Metabolism

    Volume 9, Issue 5, September 2007, Pages: 617–629, G. Mathur, B. Noronha, E. Rodrigues and G. Davis

    Version of Record online : 21 AUG 2006, DOI: 10.1111/j.1463-1326.2006.00644.x

  17. Receipt of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers among Medicare beneficiaries with diabetes and hypertension

    Journal of Pharmaceutical Health Services Research

    Volume 5, Issue 1, March 2014, Pages: 67–74, Junling Wang, Satya Surbhi and Julie W. Kuhle

    Version of Record online : 4 NOV 2013, DOI: 10.1111/jphs.12036

  18. You have free access to this content
    A Review of Olmesartan Medoxomil Monotherapy: Antihypertensive Efficacy Similar to That of Other Angiotensin II Receptor Blocker/Hydrochlorothiazide Combinations?

    Congestive Heart Failure

    Volume 8, Issue 6, November/December 2002, Pages: 313–320, Mark Greathouse

    Version of Record online : 12 JUN 2007, DOI: 10.1111/j.1527-5299.2002.02077.x

  19. Measures to enhance angiotensin-receptor blocker prescribing efficiency in Belgium following generic losartan: impact and implications for the future

    Journal of Pharmaceutical Health Services Research

    Volume 4, Issue 3, September 2013, Pages: 173–181, Steven Simoens, Kristien De Bruyn, Jamilette Miranda, Marion Bennie, Rickard E. Malmström and Brian Godman

    Version of Record online : 17 JUN 2013, DOI: 10.1111/jphs.12024

  20. Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: Challenges in Comparative Effectiveness Using Medicare Data

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 5, May 2011, Pages: 674–682, S Setoguchi, WH Shrank, J Liu, JC Lee, U Saya, WC Winkelmayer and NA Dreyer

    Version of Record online : 30 MAR 2011, DOI: 10.1038/clpt.2011.17